AbCellera Biologics Inc. (ABCL) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abcellera Biologics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425b-30b5-74a0-b92e-c7a133af411e Created: 2026-08-27T08:34:29.745Z Duration: 2665.9526 Channels: 1 00:00:00.000 -- 00:00:02.480 Good afternoon, and welcome to AbCellera's 00:00:02.480 -- 00:00:05.840 Q1 twenty twenty six Business Update Conference Call. 00:00:06.080 -- 00:00:08.000 My name is Ben, and I will facilitate 00:00:08.000 -- 00:00:10.639 the audio portion of today's interactive broadcast. 00:00:10.960 -- 00:00:13.120 After today's prepared remarks, there will be a 00:00:13.120 -- 00:00:15.155 question and answer session. If you would like 00:00:15.155 -- 00:00:17.555 to ask a question, please press star one 00:00:17.555 -- 00:00:19.314 to raise your hand. If you would like 00:00:19.314 -- 00:00:22.035 to withdraw your question, please press star one 00:00:22.035 -- 00:00:22.755 again. 00:00:23.154 -- 00:00:24.675 At this time, I would like to turn 00:00:24.675 -- 00:00:27.074 the call over to Trinh Stein Mart, AbCellera's 00:00:27.074 -- 00:00:29.715 Chief Legal and Compliance Officer. You may proceed. 00:00:31.940 -- 00:00:34.660 Thank you. Hello everyone. Thank you for joining 00:00:34.660 -- 00:00:37.620 us for AbCellera's first quarter twenty twenty six 00:00:37.620 -- 00:00:40.820 earnings call. I'm Trent Steinmartt, AbCellera's Chief Legal 00:00:40.820 -- 00:00:42.180 and Compliance Officer 00:00:42.545 -- 00:00:45.745 Doctor. Carl Hansen, AbCellera's President and CEO 00:00:45.984 -- 00:00:49.344 Doctor. Sarah Neunberg, AbCellera's Chief Medical Officer and 00:00:49.344 -- 00:00:52.464 Andrew Booth, AbCellera's Chief Financial Officer are speaking 00:00:52.464 -- 00:00:53.585 on today's call. 00:00:54.065 -- 00:00:56.464 During this call, we may make statements about 00:00:56.464 -- 00:00...